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shis article is the latest in the series of literature reviews that
ave appeared in the Journal. We have attempted to
ighlight important recent literature and new trends in
ingle-photon emission computerized tomography (SPECT)
yocardial perfusion imaging, cardiac positron emission
omography (PET), cardiac computerized tomography
CT), and cardiac magnetic resonance imaging (MRI).
ith rare exceptions, these articles were published between
anuary 1, 2003, and May 31, 2004, in the English-language
iterature. Space considerations have forced us to quite
rbitrarily include some articles and exclude others. We
pologize in advance to those whose work we may have
nadvertently overlooked or consciously excluded. Many of
he articles that we have not described were very well done
nd published in prominent journals. In many cases, we felt
hat they were confirmations of previous literature on the
ame subject and, therefore, of lesser interest to the reader-
hip. Time and the advance of science are likely to prove us
rong in several cases.
We have chosen to organize the literature around topical
hemes rather than imaging modalities in an attempt to
ncourage you to think broadly rather than simply within a
silo” of the imaging modality of particular interest to you.
ECHNICAL ADVANCES
PECT myocardial perfusion imaging. Although SPECT
yocardial perfusion imaging is a very mature modality,
mportant reports describing and evaluating technical ad-
ances continue to appear. Narayanan et al. reported a very
igorous receiver-operating characteristic analysis of the
ffects of ordered-subset expectation maximization with
ttenuation correction (AC), scatter correction (SC), and
esolution compensation (RC) on 100 patients using seven
ifferent observers (1). The combination of AC  SC 
C provided a greater area under the receiver-operating
haracteristic curve for the overall detection of coronary
rtery disease (CAD), as well as for perfusion defects in the
eft anterior descending and left circumflex territories.
Manrique et al. (2) reported that photon energy recovery
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Manuscript received July 23, 2004; accepted August 4, 2004.or scatter correction improved the accuracy of left ventric-
lar (LV) volume measurement in phantoms, and increased
mage contrast and LV volume in patients.
Grossman et al. (3) reported that a gender-independent
ormal database for attenuation-correction studies signifi-
antly improved specificity and normalcy rate without a
ignificant loss of sensitivity.
Svensson et al. (4) reported less positive results from the
pplication of three widely utilized software packages for
uantitation to 50 consecutive patients. The summed dif-
erence score classification derived from the software pack-
ges disagreed in nearly half of the patients and disagreed
arkedly in 12%.
ardiac PET. Several studies reported on the use of gated
uorine-18 fluorodeoxyglucose (FDG) cardiac PET imag-
ng. Croteau et al. (5) performed list-mode PET studies and
chocardiography in rats. Agreement between PET and
cho for volumes (R2  0.49 for diseased rats) and for
jection fraction (R2  0.56) was only fair. Saab et al. (6)
ompared gated FDG PET with radionuclide angiography
n 48 patients. Global ejection fractions by the two tech-
iques correlated closely (R  0.83). There was moderate
greement in the assessment of regional wall motion score
  0.50).
Two studies compared gated FDG PET with MRI.
chaefer et al. (7) found that ejection fractions measured by
he two techniques were highly correlated (R  0.95),
lthough PET did systematically underestimate ejection
raction by a mean of 2.7 percentage points. Regional wall
otion analysis showed good agreement (  0.62).
reiberg et al. (8) compared gated FDG PET with MRI in
heart phantom and 12 healthy subjects. Left ventricular
olume and wall thickness were measured accurately in the
hantom. In the healthy subjects, gated PET underesti-
ated regional wall motion and end-diastolic volumes.
T. Computerized tomography scanners have changed
apidly in the past five years such that the latest generation
f scanner, the 16-detector helical scanner, provides robust
ardiac imaging. New applications of cardiac CT have
ecome possible, which will be discussed in the various
ubsections.
RI. The biggest change in MRI in recent years has been
he introduction of clinical scanning at 3-T. In MRI, the
ignal received is proportional to the strength of the magnet.
ntil recently, the maximum allowable clinical field
trength was 1.5-T. However, in 1998 the Food and Drug
dministration increased the allowable field strength from
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Year in Cardiac Imaging November 16, 2004:1937–44.5-T to 4-T. By 2002, vendors were producing clinical 3-T
canners designed to image the whole body. In the past year,
ix initial technical papers using cardiac MRI at 3-T
ppeared. Most of these papers sought to document that the
heoretical advantages from 3-T imaging could be achieved
n practice.
McGee et al. (9) showed increasing the field strength
rom 1.5-T to 3-T resulted in a 1.83 increase in signal-to-
oise ratio in five volunteers. They also tested parallel
maging at 3-T. Parallel imaging is a technique that de-
reases scan time at the expense of signal. Using phantoms,
hey achieved the expected result: parallel imaging at 3-T
ut the scan time in half, but resulted in loss of signal.
owever, the 3-T parallel images still had more signal than
onparallel acquired images at 1.5-T. Using 3-T may
ddress one of the biggest limitations of MRI-long scan
imes.
The implications of 3-T scanning are unclear. However,
arly trends in neurologic and musculoskeletal imaging
uggest that once vendors optimize their systems, 3-T may
upplant 1.5-T as the standard field strength for MRI.
EFINEMENTS IN TEST INTERPRETATION
PECT myocardial perfusion imaging. Klodas et al. (10)
nd Abbott et al. (11) reported on the uncommon finding of
atients with ischemic electrocardiogram (ECG) changes
ut normal myocardial perfusion images after vasodilator
tress (Fig. 1). Both studies found that older women
omprised more than 82% of this uncommon population.
uring subsequent follow-up, the rate of cardiac death or
onfatal myocardial infarction (MI) ( 3.5% per year over
he next three years in both studies) greatly exceeded that
bserved for normal images. Dahlberg and Leppo (12)
iscussed both articles in an accompanying editorial.
Abidov et al. (13) clarified the prognostic value of
ormal-stress SPECT images in the presence of transient
schemic dilation (TID) of the left ventricle. Patients in the
igure 1. Survival free of myocardial infarction in patients with normal
denosine stress single-photon emission computerized tomography scans
nd either negative or positive electrocardiographic (ECG) changes (11).ighest TID quartile (1.21) had a higher rate of cardiac Fvents regardless of stress type. The authors advised caution
n the use of prognostic statements implying low-risk when
ID is present, especially in patients with typical angina,
dvanced age, and diabetes.
A second study by Abidov et al. (14) demonstrated the
mportance of the hemodynamic response to adenosine
nfusion during stress myocardial perfusion imaging. Pa-
ients with a high rest heart rate and low peak-to-rest heart
ate ratio had an increased risk of cardiac death, even after
djustment for image findings.
Hayes et al. (15) demonstrated that when prone SPECT
maging was used to clarify the significance of equivocal
nferior wall perfusion defects, subsequent hard event rates
ere similar to those obtained with supine-only imaging.
Finally, De Winter et al. (16) reported on the day-to-day
ariability in global LV function and perfusion by resting
ated SPECT. The 95% limits of agreement (Table 1)
rovide important guidance for the use of gated SPECT to
ssess changes in function and perfusion over time in
atients with heart failure.
YOCARDIAL VIABILITY
PECT myocardial perfusion imaging. Van der Burg et
l. (17) reported on 153 survivors of sudden death, most of
hom underwent implantation of a defibrillator. Survival
ree of recurrent ventricular arrhythmias was related to the
resence of extensive scar tissue and ejection fraction30%.
hus, although stress-rest SPECT demonstrated jeopar-
ized myocardium and affected subsequent revasculariza-
ion, neither jeopardized myocardium nor revascularization
nfluenced outcome on multivariate analysis. Dobert et al.
18) reported pilot data on 26 patients who underwent
ntracoronary infusion of bone marrow-derived cells or
irculating blood-derived endothelial progenitor cells after
cute MI. Myocardial signal intensity in the infarct zone
ncreased significantly on both SPECT and PET, suggest-
ng that either might prove useful in monitoring therapeutic
ffect.
The FDG studies often require time-consuming hyper-
nsulinemic euglycemic clamping. Kam et al. (19) reported
he simpler use of the nicotinic acid derivative acipimox in
0 non-diabetic patients for FDG SPECT and simulta-
eous dual-isotope tetrofosmin perfusion imaging. The
able 1. Reproducibility of Gated SPECT Measurements in
atients With Heart Failure (16)
Parameter
Mean
Difference
95% Confidence Limits
Upper Lower
VEF (%) 0.9 5.1 6.9
VEDV (ml) 3 23 17
VESV (ml) 4 24 16
VEF  left ventricular ejection fraction; LVEDV  left ventricular end-diastolic
olume; LVESV  left ventricular end-systolic volume; SPECT  single-photon
mission computed tomography.DG image quality was good in 46 patients (92%) and still
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November 16, 2004:1937–44 Year in Cardiac Imagingnterpretable in the other four patients (8%). Tetrofosmin
PECT image quality was maintained.
ardiac PET. Yang et al. (20) performed rest and stress
ubidium perfusion and FDG PET imaging in 64 consec-
tive patients with non–Q-wave MI and Q-wave MI.
schemic and viable myocardium was more common in the
bsence of Q waves.
Beanlands et al. (21) describe the rationale, design, and
ethods of the PARR-2 study. This important trial in four
anadian centers will evaluate patient outcome and cost-
ffectiveness using an FDG cardiac PET-guided approach
o management of patients with CAD and severe LV
ysfunction. It is hoped that this trial will complement the
ngoing U.S. (STITCH) and United Kingdom trials ex-
loring this same issue.
T. As mentioned earlier, there has been recent interest in
sing CT for functional questions, including viability. In
wo patient studies, CT scans performed for other indica-
ions were retrospectively reviewed for findings of MI. In
he larger of the two studies, Nikolaou et al. (22) reviewed
T coronary angiograms in 106 patients. Twenty-seven of
hese patients were thought to have had previous MI based
n coronary angiography and clinical history. Using CT, 23
f the 27 patients were correctly identified as having had
revious MI based on perfusion defects and wall motion
bnormalities from retrospectively reconstructed gated
mages.
In the smaller study, Gosalia et al. (23) retrospectively
dentified 18 patients who had an MI and subsequently
nderwent a contrast-enhanced CT scan, performed for an
nrelated indication, within a month. They then identified
9 control patients who had also had CT scans. Comput-
rized tomography scans were reviewed for areas of de-
reased enhancement, which was interpreted as a finding of
I. Using these criteria, CT correctly identified 15 of the
8 patients with MI (sensitivity  83%) and 18 of the 19
atients without MI (specificity  95%). Positive predictive
alue was 94% and negative predictive value was 86%.
lthough very preliminary, these studies suggest a poten-
ially very significant clinical application as CT is already
idely used in patients with acute chest pain. Combining
his application with direct coronary imaging could be
articularly powerful.
RI. In contrast to CT, there is extensive literature about
he use of MRI for detecting myocardial viability. The most
ommonly used MRI method is delayed contrast enhance-
ent. With this technique, an intravascular contrast agent
gadolinium-DTPA) is injected. The contrast agent rapidly
ashes in and out of normal myocardium. However, the
ontrast agent leaks into the interstitium of infarcted tissue
nd washes out slowly. Images obtained 10 to 15 min after
njection show infarcted tissue as enhanced compared to
ormal myocardium. In prior years, this method was exten-
ively validated in animals and humans. However, in the
ast year several authors took different approaches to MRI-
elayed enhancement for viability. cNelson et al. (24) compared the ability of dobutamine
cho and thallium SPECT to detect scars of different
ransmural extents, using MRI as the gold standard.
This study is a departure from the recent literature in two
mportant ways. First, the authors use transmural extent of
car as an outcome variable. The ability to detect transmural
xtent of scar has long been cited as an advantage of MRI.
owever, to date there have been few research or clinical
pplications for this information.
Second, the authors use MRI as the gold standard against
hich they compare the established methods of Thallium
PECT and dobutamine stress echo. This is a fundamental
eparture. Most recent studies have used established meth-
ds as gold standards against which MRI has been mea-
ured. The reversal of roles in this study indicates growing
cceptance of MRI.
Wellnhofer et al. (25) questioned the superiority of
elayed contrast enhancement to wall motion analysis as a
eans for predicting recovery of function after revascular-
zation. They imaged 29 patients with chronic coronary
rtery disease. In all patients they obtained rest and low-
ose dobutamine stress MRI wall motion images, as well as
RI delayed enhancement. Three months after revascular-
zation they re-imaged the patients and subjectively graded
mprovement in regional function
They found that MRI-visualized improvement in wall
otion from rest to low-dose dobutamine better predicted
ecovery of function than did MRI-visualized delayed en-
ancement. The area under the receiver operator curve for
all motion analysis was 0.838. The area for delayed
nhancement was slightly, but significantly less, at 0.728.
his raises interesting questions about the optimal physio-
ogic approach for predicting recovery of function, but also
oints out the ability to image multiple cardiac parameters
t one examination.
ARDIAC RESYNCHRONIZATION THERAPY
ultiple studies of cardiac resynchronization therapy
CRT) were published (Table 2) (26–33). These studies
enerally reported on small numbers of patients with LV
ysfunction and increased ECG QRS duration. The studies
ssessed the impact of CRT at varying intervals after
mplantation. Control measurements were performed either
t baseline before pacemaker implantation or after turning
he pacemaker off for a period of hours to days.
PECT. Using gated SPECT, Sciagra et al. (26) suggested
hat CRT was not effective in the presence of a severe
aseline perfusion defect.
ET. Cardiac resynchronization therapy appears to have
odest effects on myocardial perfusion (Table 2), although
ne study using sestamibi (Nowak et al. [30]) reported an
mprovement in regional heterogeneity. Regional heteroge-
eity in FDG uptake resolved with CRT, reflecting an
ncrease in FDG uptake in the septum. Three studies using
arbon-11 acetate demonstrated similar results: an increase
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Year in Cardiac Imaging November 16, 2004:1937–44n stroke volume, unchanged Kmono, and an increase in
yocardial efficiency. Braunschweig et al. (29) showed an
pparent improvement in myocardial oxygen uptake with
RT during dobutamine infusion without any change in
yocardial blood flow, suggesting an improvement in over-
ll oxygen utilization at the mitochondrial level.
RI. In a dog model, Sorger et al. (34) described the torsion
f the left ventricle during cardiac pacing. Employing tagged
RI, a method in which myocardial displacements can be
onverted into quantitative measures of mechanical motion,
hey found differences in ventricular torsion among atrial,
niventricular, and biventricular pacing.
This group has published extensively on this topic.
owever, to date there have been no human applications of
his method because that would involve performing MRI on
atients with pacemakers—not an easy task, as pacemakers
ave long been an absolute contraindication to MRI scan-
ing. But that may be changing.
Martin et al. (35) performed the first prospective study of
he safety of MRI scanning patients with pacemakers.
ifty-four sequential, non-pacemaker-dependent patients
nderwent 62 clinically indicated MRI scans. No adverse
vents occurred. Thirty-seven percent of the leads under-
ent threshold changes, but only 2 of 107 (1.9%) required
change in programmed output. Given the rapid increase in
atients undergoing CRT, more studies like this one will be
elpful to define when these patients can undergo an MRI.
IAGNOSIS/PROGNOSIS OF CAD
iabetes mellitus. Two studies suggested a potential role
or stress SPECT imaging in screening asymptomatic dia-
etics. Miller et al. (36) compared stress SPECT in 1,738
symptomatic diabetics to both symptomatic diabetics and
on-diabetics. Abnormal scans were present in nearly 60%
f both asymptomatic and symptomatic diabetics, and
ignificantly more common than in either asymptomatic or
ymptomatic non-diabetics (Fig. 2). High-risk scans fol-
igure 2. Prevalence of abnormal single-photon emission computerized
omography studies in 1,738 asymptomatic diabetics, 2,998 symptomatic
iabetics, 6,215 asymptomatic non-diabetics, and 16,214 symptomatic
on-diabetics (36).lowed a similar pattern (Fig. 3).Ta
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November 16, 2004:1937–44 Year in Cardiac ImagingZellweger et al. (37) examined the prognostic value of
ual-isotope SPECT imaging in 1,737 diabetics. The rate
f objective evidence of CAD was 39% in 826 diabetic
atients without symptoms, who had a subsequent critical
vent rate of 3.4%. Both of these findings were similar to
hose found in diabetic patients with angina. Diabetic
atients with shortness of breath had a higher rate of
bjective evidence of CAD and worse subsequent outcomes.
Berman et al. (38) reported the impact of diabetes in
,173 patients who underwent adenosine sestamibi and rest
hallium SPECT. Subsequent cardiac death was more likely
n diabetic women compared to other patients, and in
atients with insulin-dependent diabetes compared to pa-
ients with non-insulin-dependent diabetes.
Peterson et al. (39) employed cardiac PET to explore the
mpact of obesity alone on myocardial fatty acid metabolism
nd efficiency. Obesity was a significant predictor of in-
reased myocardial oxygen consumption and decreased
yocardial efficiency. Insulin resistance correlated with fatty
cid uptake, utilization, and oxidation.
ther patient subgroups. Lima et al. (40) reported stress
PECT results in 328 patients age 74 years or older.
bnormal studies were common, particularly in men, pa-
ients with chest pain, and those with resting or exercise
T-T abnormalities. Patients with normal perfusion images
ad an annual hard event rate of 1.0% per year, and those
ith abnormal images had an annual hard event rate of
4.3% per year. Studies of SPECT imaging before renal
ransplantation, before liver transplantation, and in patients
ith significant aortic stenosis showed potential benefits but
lso limitations (41–43).
oronary calcium. Coronary calcium as detected by CT
as been a controversial topic. The test has proliferated in
he community faster than data to support it. In 2000 the
merican Heart Association noted the paucity of studies
sing hard events as end points and showing incremental
enefit of coronary calcium over traditional risk factors. In
igure 3. Prevalence of high-risk single-photon emission computerized
omography studies (based on summed stress score) in the same groups
hown in Figure 2 (36).he past year three studies were published that used hardnd points (death or myocardial infarction) and applied
ultivariate analysis to correct for risk factors.
Kondos et al. (44) identified 8,855 subjects and obtained
ollow up at a mean of 37 months in 5,635. Their popula-
ion included 4,151 men and 1,484 women, whom they
nalyzed separately. Their variables in their multivariate
odel were age, smoking history, diabetes, hypercholester-
lemia, and coronary calcium. In men, after adjusting for
ther variables, Kondos et al. (44) found that the presence of
ny coronary calcium conferred a relative risk of 3.86. In
omen, the multivariate analysis did not show an increase in
elative risk with coronary calcium. The authors suggested
hat this negative result was due to the smaller number of
omen in their study.
Shaw et al. (45) examined a group of 10,377 individuals
or all-cause mortality after a mean of 5.0 years. Their
ultivariate model included age, gender, diabetes, family
istory of coronary disease, hyperlipidemia, hypertension,
moking, and coronary calcium scores. They found that
ven low coronary calcium scores (11 to 100) conferred a
tatistically significant risk of death (relative risk  1.64)
fter adjusting for other risk factors.
Greenland et al. (46) studied 1,312 subjects without
iabetes, but with at least one coronary risk factor, who were
ollowed for 8.5 years. Their model had two variables: the
ramingham risk score and the coronary calcium score.
ncreasing coronary calcium predicted adverse outcome even
fter adjustment for Framingham risk score. Although a
maller study than the ones by Kondos and Shaw, the study
y Greenland had the advantages of being prospective and
f direct measurement of the risk factors.
mpact of clinical factors. Two studies addressed the issue
f pretest likelihood in patient management. Poornima et al.
47) reported that SPECT imaging was of limited prognos-
ic value in patients with low clinical risk and a low-risk
uke treadmill score. In contrast, patients with high-
linical risk and a low-risk Duke treadmill score had an
nnual cardiac mortality that was not low and were appro-
riately risk stratified by SPECT imaging. Hachamovitch et
l. (48) reported on the value of SPECT imaging in patients
ith a high pretest likelihood of CAD (0.85) without
revious CAD. Single-photon emission computerized to-
ography imaging provided important incremental prog-
ostic value and was a more cost-effective initial strategy,
ompared to initial treadmill testing or direct referral to
atheterization. Beller and Watson (49) discussed the im-
lications of both articles in an accompanying editorial.
irect coronary imaging. It appears that direct coronary
maging with CT is becoming feasible, at least in select
atients. Two papers were published on the topic, both
rom Europe, both using 16-detector CT scanners. These
apers suggest that CT coronary angiography can achieve
igh negative predictive values, even in high-risk popula-
ions. However, CT is still limited by the low heart rates
equired and the limitations on the size of vessels visualized.
Ropers et al. (50) performed CT coronary angiograms on
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Year in Cardiac Imaging November 16, 2004:1937–447 patients scheduled for cardiac catheterization. To de-
rease motion artifacts, patients received oral beta-blockade
efore the scan, and the mean heart rate for the group was
9 beats/min. Though the authors limited themselves to
essels with a diameter 1.5 mm, 12% of the vessels were
till uninterpretable. However, accepting these limitations,
opers et al. (50) showed sensitivity of 92% and specificity
f 93% for detecting a50% diameter stenosis in the vessels
ncluded in the study. The positive predictive value was 79%
nd their negative predictive value was an impressive 97%.
In a study by Mollet et al. (51), 128 patients scheduled for
ardiac catheterization underwent CT coronary angiogra-
hy. Again, patients received beta-blockers, and the inves-
igators limited themselves to vessels 2.0 mm in diameter.
or detecting a 50% diameter stenosis the study reported
ensitivity of 92%, specificity of 95%, and positive predictive
alue of 79%. Again, negative predictive value was impres-
ive at 98%.
These results are encouraging but should be interpreted
ith caution. Early studies with expert readers and cooper-
tive patients typically produce excellent results. However, it
s very encouraging that separate groups achieved similar
esults. The introduction of faster scanners may further
mprove these results.
ost-test clinical management. Another article by
achamovitch et al. (52) addressed the important issue of
he risk of subsequent hard events after a normal stress
PECT study. Patients without previous CAD had a
niform risk over time, but patients with known CAD had
n increasing risk over time. Detailed tables provided
uidance regarding the appropriate timing of repeat testing
ollowing a normal SPECT study. A third article by
achamovitch et al. (53) related inducible ischemia on
tress SPECT imaging with the survival benefit of early
evascularization. Patients with no or mild ischemia ap-
eared to have a survival advantage with medical therapy,
here as those with moderate to severe ischemia had a
urvival benefit with revascularization, which increased in
igher risk patients.
Bugiardini et al. (54) reported on women with angina,
bnormal stress SPECT studies, normal coronary angio-
rams, and diffuse vasoconstriction during acetylcholine.
ver subsequent follow-up of 10 years, a majority devel-
ped angiographic CAD, suggesting that such abnormal
PECT studies may not always be “false positives.”
cute chest pain management. Kontos et al. (55) pub-
ished a cost study comparing alternative approaches to the
anagement of patients with acute chest pain in the
mergency department. Use of acute SPECT imaging in
ow-risk patients was associated with reduced costs, lower
ates of angiography, and shorter lengths of stay.
olecular imaging. Molecular imaging is the noninvasive
maging of cellular and molecular events. Better under-
tanding of molecular events has led to recent interest in
maging new markers, which is possible with SPECT, PET,
nd MRI. iThe numerous papers in the field cover diverse topics and
re well beyond the scope of this article. As examples, we
ave chosen several papers describing attempts to label the
v3 integrin (a surface receptor involved in angiogenesis),
atrix metalloproteinases, and selected individual cells.
PECT. Meoli et al. (56) imaged the v3 integrin with
n indium-111-labeled. They showed increased activity of
heir v3 tracer in the region of an infarct in animal
odels, suggesting that the v3 integrin, and therefore
ngiogenesis, may be imaged. However, they were unable to
uantify the absolute amount of tracer.
Aicher et al. (57) labeled circulating human endothelial
rogenitor cells with indium-111 oxime, the same label used
or clinical white blood cell labeling. They intravenously
njected the labeled endothelial progenitor cells into eight
ude mice with myocardial infarctions. After sacrifice they
howed increased radioactivity in the area of infarction. The
nability to absolutely quantitate cells in the area of infarc-
ion is again a limitation of this promising approach.
Schefers et al. (58) modified the broad-spectrum matrix
etalloproteinase inhibitor CGS 27023A for labeling with
odine-123. They demonstrated the feasibility of in-vivo
maging in a mouse model of carotid artery ligation.
RI. Winter et al. imaged the v3 receptor using MRI
59). They developed a novel nanoparticle, a lipid-
ncapsulated perfluorocarbon with 90,000 particles of MRI
ontrast agent attached to its surface. They targeted this
anoparticle to the v3 receptor in cholesterol-fed rabbits
nd found increased signal in the aortic walls of rabbits that
ere injected with the targeted particles. They achieved a
egree of histologic confirmation by showing neovascularity
n the aortas including colonization of vessels by v3.
There has been extensive interest in labeling cells with
ron particles for imaging with MRI. For technical reasons
gadolinium-based label, like the one used by Winter et al.
59) would be preferable. However, as iron is nontoxic and
aken up by a variety of cells, most of the papers on this
opic have used various forms of iron labeling.
Hill et al. (60) created an iron-labeled fluorescent particle.
he iron part of the particle allowed for noninvasive
maging with MRI. The fluorescent part of the particle
llowed for confirmation at histology. They incubated the
esenchymal stem cells (MSCs) with the particle and
hrough a catheter injected them directly into infarcted
issue in swine. Serial MRIs performed at 4, 8, and 21 days
howed the expected signal changes in the myocardial tissue
nd histology confirmed the presence of intact MSCs.
At a more basic level, Frank et al. (61) showed that one
oes not need to have novel or unique particles to perform
ell labeling. They incubated several commercially available
ransfection agents with commercially available iron parti-
les. They then took their transfection agent/iron particle
ombination and incubated them with different cell lines.
hey showed that their cells took up the transfection
gent/iron particle combination better than incubation with
ron particles alone, and that cell viability and proliferation
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November 16, 2004:1937–44 Year in Cardiac Imagingere not affected by the presence of the label. They also
uantified the MRI signal produced by their labeled cells.
ONCLUSIONS
e hope that this review has highlighted some of the
mportant emerging literature in cardiac imaging. It has
een an educational experience for us. If we have stimulated
ou to read at least a few of the original articles, we hope
hat it will have also been an educational experience for you.
eprint requests and correspondence: Dr. Raymond J. Gibbons,
ayo Clinic, Gonda 5, 200 First Street, SW, Rochester, Minne-
ota 55905. E-mail: gibbons.raymond@mayo.edu.
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